Code
|
Feb 21,2018 Morning
|
HN10100290007
|
VDR, CYP24A1, CYP27B1 gene expression analysis in schizophrenia patients
|
HN10102630259
|
Investigation of the role of apoptosis, necroptosis and DNA damage signaling pathways in multiple sclerosis
|
HN10102650275
|
Relationship between COMT polymorphism and opioid addiction in zabol (Iran)
|
HN10102570240
|
Association analysis between interleukin 1 beta locus -511 gene polymorphism and bipolar I disorder,a case control study in an Iranian population
|
HN10101160063
|
Hydroalcoholic extract of Anchusa italica injection protects against global cerebral ischemia–reperfusion injury via nitric oxide mechanism in rats
|
HN10102290193
|
Whole Exome Sequencing reveals de novo mutations in POGZ and KMT2D genes of Iranian individuals with NDD
|
HN10102340270
|
The first world report of a homozygous mutation in inositol monophosphatase 1 (IMPA1) gene two boy with autismin an Iranian family
|
HN10100650071
|
Role of epigenetics factor (miRNA) in diagnose and treatment of depression
|
HN10100490057
|
A Systematic review of vitamin D pathway genetic variation and Risk of Breast Cancer
|
HN10101940169
|
Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor,TIMP1 genes in Iranian schizophrenic patients
|
HN10101110059
|
The Study of association between polymorphism Ser311Cys in DRD2 in patients with Schizophrenia reffred to a spechialized psychiatric hospital in Yazd
|
HN10100530243
|
Computational neurogenetics models : integration of gene regulatory networks and artificial neural networks
|
HN10102050187
|
MicroRNAs mediate regulatory effects on cerebral ischemia process
|
HN10102890321
|
Bioinformatic prediction of Long-Non Coding RNAs as Regulatory Candidates of ADRB2 Gene Expression
|
HN10100780177
|
Gene expression and methylation analysis on MBP, TCF4, EGR1 genes in the blood of patients with schizophrenia and its psychopathology, intelligence and cognitive impairments
|
HN10101140084
|
The Study of association between Val158Met polymorphism in COMT gene and deleting polymorphism of Glutathione S-transferasesM1 gene in patient with Schizophrenia reffered to a specialized psychiatric hospital in Yazd
|
HN10102020168
|
Evaluation of CXCL8 gene expression in patients with bipolar disorder
|
HN10101180067
|
A novel candidate gene, SNRK, causes Bardet-Biedl Syndrome in an Iranian Family
|
HN10100350010
|
Novel mechanisms mediated by FMRP in Fragile X syndrome (FXS)
|
HN10100540022
|
Genetic landscape of Non-syndromic Intellectual disability
|
HN10101540147
|
Epigenetic reprogramming and regulation of neural cell fate using small molecules to cure neurological disorders: Is it possible?
|
HN10102620256
|
Investigation of association between coagulation factor v, factor II, methylenetetrahydrofolate reductase, tumor necrosis factor alpha and plasminogen activator inhibitor genetic variations and stroke: a case-control study in an Iranian population with high incidence rate of stroke
|
HN10102620255
|
The association of miR-221 rs113054794, miR-146a rs2910164 and miR-34a rs369892834 polymorphisms with stroke risk
|
HN10102620254
|
Association Study on SNPs of PPAP2B, ZC3HC1 and ADAMTS7 genes with Stroke and Myocardial infarction
|
HN10102620252
|
Analysis of polymorphisms of paraoxonase, coagulation factor 13, platelet glycoprotein IIb, β2 adrenergic receptor and angiotensin II receptor genes in patients with stroke problem
|
HN10102620251
|
The association of AGT, PDE4D and IL10 gene polymorphisms and stroke risk
|
HN10102620250
|
The association study of APOE Ɛ2 Ɛ3 Ɛ4, IL-6-572GC, IL6-174GC, ACE InsertionDeletion, and eNOS4b4a Polymorphisms in Iranian Stroke patients
|
HN10102620249
|
Association between mir-125a and mir-30c gene polymorphisms and ischemic stroke; a case control study
|
HN10102620248
|
Association of the miR-499 and miR-608 Polymorphisms With ischemic stroke in northeast Iran Population
|
HN10102620247
|
Therapeutic approaches for Facioscapulohumeral Muscular Dystrophy(FSHD)
|
HN10102620246
|
Review and case series on the genetic and epigenetic alteration in Facioscapulohumeral muscular dystrophy
|
HN10100880045
|
A Study of CAG repeat instability of HTT gene following spermatogenesis,by single sperm analysis
|
HN10100180004
|
Radiological Survey in intraventricular Cavernomas
|
HN10100440020
|
Epigenetic mechanisms of Central nervous system (CNS) disorders is the key in pharmacoepigenomics development
|
HN10101230226
|
Expression of influence BKN2A and PTEN In Glioblastoma Multiforme
|
HN10101960160
|
Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
|
HN10102360198
|
Genotoxicity and cytotoxicity of mineral trioxide aggregate and calcium enriched mixture cements on L929 mouse fibroblast cells
|
HN10102370199
|
Evaluation of in vitro toxicity of peptide (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β- cyclodextrin derivative, a novel drug carrier, in PC-12 cells
|
HN10101560305
|
genotype-phenotype correlationin in Iranian patients with Kennedy disease
|
HN10100790069
|
Evaluation the possibility of induction of neurogenic differentiation of mesenchymal stem cells using Butylated hydroxyl anisol and curcumin
|
HN10101510152
|
Multiple Sclerosis and mitochondrial gene variation: A systematic review
|
HN10102380203
|
Molecular Analysis of SNP (rs16147) polymorphism of Neuropeptide Y gene in the autism spectrum disorders
|
HN10102760298
|
Detection of MFSD8 gene Mutation in Neuronal ceroid lipofuscinosis (type 7): A Case Report
|
HN10101790141
|
Regulation of Gene Expression in Neural Stem Cell Differentiation and Self-Renewal
|
HN10101950154
|
Case Report: Limb-girdle Muscular Dystrophy with New Mutation in SGCB gene
|
HN10102550228
|
Detection of PANK2 Gene Mutation in PKAN: A Case Report
|
HN10102670282
|
Case report: members of a family with ADHD and t (2; 7) (q33; q31.2) karyotype
|